We all are subjected to different circumstances and situations while growing up. These diverse experiences help shape our future either consciously or unconsciously. The experiences have played a significant role in shaping the career choices of many youths. In addition, they act as a driving force towards the achievements of personal desires. A good example is the cancer researcher, Dr. Clay Siegall of Seattle Genetics, who made a career choice based on his experience when growing up.
Dr. Siegall’s career on the development of cancer therapies came about after experiencing the pain of watching a loved one suffer and ultimately die of the ailment. More so, Siegall had a soft spot for medicine from his childhood days. With the modern development in the technology world, the idea of practicing medicine with the help of these new ways charmed him the more, and he wanted to experience their power as they fought the dreaded diseases. At some point in his early twenties, his father was diagnosed with cancer, and he had to watch him suffer the seemingly brutal treatments that, to him, did more harm than good. Clay’s father later on died, and this made his desire more real. He resolved to search for better ways of treating the killer disease.
Dr. Clay Siegall is the founder and the CEO of Seattle Genetics. The biotech company specializes in the formulation of targeted cancer therapy drugs. He has seen his company develop proprietary drugs like the ADCs that have been effective. Through their sale, Clay has injected substantial revenues into the business, and it is now known all over. He attained a Bachelor of Science in Zoology from the University of Maryland and later earned a Ph.D. in Genetics from the University of George Washington.
Dr. Clay Siegall career at Seattle Genetics has been marked with remarkable success even though he has also worked in other reputable firms. He has rendered his unique services to Bristol-Myers Squibb Pharmaceutical Research Institute, the National Institute of Health, and also the National Cancer Institute. More so, he serves on the Board of Alder Bio-pharmaceuticals. Clay has also authored numerous scientific papers and holds more than 15 patents. His focus, hard work, and passion have been the drivers of his career success, and he advises other professionals to apply them in their operations.